Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. SPY
3. APTX:CN
4. IQMX
5. EROC
6. MSTR
7. RIVN
8. TSLA
9. MSFT
10. SEER

Go back to Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Aviragen Therapeutics (AVIR) Tops Q4 EPS by 3c

February 28, 2023 4:34 PM EST

Aviragen Therapeutics (NASDAQ: AVIR) reported Q4 EPS of ($0.41), $0.03 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

... More